Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Ruggeri

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Clinical Drug Investigation|September 15, 2021
Cost-Effectiveness Analysis of Tapentadol Versus Oxycodone/Naloxone in both Branded and Generic Formulations in Patients with Musculoskeletal PainMatteo Ruggeri, Alessandro Signorini, Silvia Caravaggio, et al.
International Journal of Environmental Research and Public Health|November 7, 2020
The Determinants of Out-of-Pocket Expenditure in IBD Italian Patients. Results from the AMICI SurveyMatteo Ruggeri, Carlo Drago, Chiara Cadeddu, et al.
Clinicoeconomics and Outcomes Research : CEOR|December 5, 2015
Doctors commitment and long-term effectiveness for cost containment policies: lesson learned from biosimilar drugsEnrica Menditto, Valentina Orlando, Silvia Coretti, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|July 9, 2021
The costs of treatment resistant depression: evidence from a survey among Italian patientsMatteo Ruggeri, Carlo Drago, Donatella Mandolini, et al.
International Journal of Technology Assessment in Health Care|September 18, 2012
The harmonic study: cost-effectiveness evaluation of the use of the ultrasonic scalpel in total thyroidectomyMatteo Ruggeri, Rossella Dibidino, Marco Marchetti, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 15, 2018
Economic Evaluation of the Hepatitis C Virus Treatment Extension to Early-Stage Fibrosis Patients: Evidence from the PITER Real-World CohortMatteo Ruggeri, Silvia Coretti, Federica Romano, et al.
Clinical Drug Investigation|March 17, 2022
Estimation Model for Healthcare Costs and Intensive Care Units Access for Covid-19 Patients and Evaluation of the Effects of Remdesivir in the Portuguese Context: Hypothetical StudyMatteo Ruggeri, Alessandro Signorini, Silvia Caravaggio, et al.
Blood Transfusion = Trasfusione Del Sangue|May 3, 2016
Is solvent/detergent plasma better than standard fresh-frozen plasma? A systematic review and an expert consensus documentMarco Marietta, Massimo Franchini, M Lucia Bindi, et al.
Journal of Medical Screening|January 18, 2020
Economic evaluation of colorectal cancer screening programs: Affordability for the health serviceSilvia Coretti, Matteo Ruggeri, Rossella Dibidino, et al.
Journal of Nephrology|August 8, 2014
Erratum to: Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD studyMatteo Ruggeri, Antonio Bellasi, Filippo Cipriani, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Clinical Drug Investigation|September 15, 2021
Cost-Effectiveness Analysis of Tapentadol Versus Oxycodone/Naloxone in both Branded and Generic Formulations in Patients with Musculoskeletal PainMatteo Ruggeri, Alessandro Signorini, Silvia Caravaggio, et al.
International Journal of Environmental Research and Public Health|November 7, 2020
The Determinants of Out-of-Pocket Expenditure in IBD Italian Patients. Results from the AMICI SurveyMatteo Ruggeri, Carlo Drago, Chiara Cadeddu, et al.
Clinicoeconomics and Outcomes Research : CEOR|December 5, 2015
Doctors commitment and long-term effectiveness for cost containment policies: lesson learned from biosimilar drugsEnrica Menditto, Valentina Orlando, Silvia Coretti, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|July 9, 2021
The costs of treatment resistant depression: evidence from a survey among Italian patientsMatteo Ruggeri, Carlo Drago, Donatella Mandolini, et al.
International Journal of Technology Assessment in Health Care|September 18, 2012
The harmonic study: cost-effectiveness evaluation of the use of the ultrasonic scalpel in total thyroidectomyMatteo Ruggeri, Rossella Dibidino, Marco Marchetti, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 15, 2018
Economic Evaluation of the Hepatitis C Virus Treatment Extension to Early-Stage Fibrosis Patients: Evidence from the PITER Real-World CohortMatteo Ruggeri, Silvia Coretti, Federica Romano, et al.
Clinical Drug Investigation|March 17, 2022
Estimation Model for Healthcare Costs and Intensive Care Units Access for Covid-19 Patients and Evaluation of the Effects of Remdesivir in the Portuguese Context: Hypothetical StudyMatteo Ruggeri, Alessandro Signorini, Silvia Caravaggio, et al.
Blood Transfusion = Trasfusione Del Sangue|May 3, 2016
Is solvent/detergent plasma better than standard fresh-frozen plasma? A systematic review and an expert consensus documentMarco Marietta, Massimo Franchini, M Lucia Bindi, et al.
Journal of Medical Screening|January 18, 2020
Economic evaluation of colorectal cancer screening programs: Affordability for the health serviceSilvia Coretti, Matteo Ruggeri, Rossella Dibidino, et al.
Journal of Nephrology|August 8, 2014
Erratum to: Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD studyMatteo Ruggeri, Antonio Bellasi, Filippo Cipriani, et al.
Pageof 6